Atlas Trials

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

Clinical trial NCT04263584 · COMPLETED

Trial details

NCT number
NCT04263584
Sponsor
University Hospital Muenster
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B Cell Lymphoma
Start date
2020-06-19
Primary completion
2025-05-03
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.